Precigen Inc (PGEN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.81
• Market Cap: $1.36B
• EPS: $-0.41
• 52-Week High: $5.47
• 52-Week Low: $1.11

Market Sentiment

Precigen Inc currently has a Neutral sentiment score of -0.12.

About Precigen Inc

Precigen Inc (PGEN) is an innovative biotechnology company based in Germantown, Maryland, dedicated to the advancement of next-generation cell and gene therapies. By utilizing its proprietary technologies, Precigen is revolutionizing treatment approaches for cancer and autoimmune diseases, aiming to enhance patient outcomes through therapies that effectively engage the immune system. With a robust pipeline and a commitment to scientific excellence, the company is positioned to become a leader...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Precigen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PGEN pay dividends?

Precigen Inc (PGEN) does not currently pay a regular dividend.

What is PGEN's market cap?

Precigen Inc (PGEN) has a market capitalization of $1.36B with a current stock price of $3.81.